Usui T - Search Results

1

[M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].

Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Kume T, Masu C, Ishino T, Nakatsu H, et al. Igawa M, et al. Among authors: usui t. Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 1):2577-82. Gan To Kagaku Ryoho. 1989. PMID: 2673046 Clinical Trial. Japanese.

2

[Successful inhibition of bladder tumor recurrence by oral administration of UFT].

Nakamoto T, Igawa M, Usui T. Nakamoto T, et al. Among authors: usui t. Gan To Kagaku Ryoho. 1994 Apr;21(5):697-9. Gan To Kagaku Ryoho. 1994. PMID: 8154896 Japanese. No abstract available.

3

Association between patient characteristics and treatment history, and toxicity associated with methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) for advanced urothelial cancer.

Igawa M, Kadena H, Ueda M, Usui T. Igawa M, et al. Among authors: usui t. Br J Urol. 1994 Mar;73(3):263-7. doi: 10.1111/j.1464-410x.1994.tb07515.x. Br J Urol. 1994. PMID: 8162503

4

Factors affecting the outcome of patients with advanced urothelial cancer following chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin.

Igawa M, Ohkuchi T, Ueda M, Usui T. Igawa M, et al. Among authors: usui t. Cancer Chemother Pharmacol. 1992;30 Suppl:S77-80. doi: 10.1007/BF00686948. Cancer Chemother Pharmacol. 1992. PMID: 1394824 Clinical Trial.

5

Analyses of factors affecting the outcome of combination chemotherapy in patients with advanced bladder cancer.

Igawa M, Ohkuchi T, Ueda M, Usui T, Kawanishi M. Igawa M, et al. Among authors: usui t. Eur Urol. 1991;20(1):12-5. doi: 10.1159/000471651. Eur Urol. 1991. PMID: 1743224

6

[Methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer--analysis of efficacy and toxicity].

Igawa M, Kadena H, Ohkuchi T, Ueda M, Usui T. Igawa M, et al. Among authors: usui t. Nihon Hinyokika Gakkai Zasshi. 1991 Oct;82(10):1627-36. doi: 10.5980/jpnjurol1989.82.1627. Nihon Hinyokika Gakkai Zasshi. 1991. PMID: 1770701 Free article. Japanese.

7

Usefulness and limitations of methotrexate, vinblastine, doxorubicin and cisplatin for the treatment of advanced urothelial cancer.

Igawa M, Ohkuchi T, Ueki T, Ueda M, Okada K, Usui T. Igawa M, et al. Among authors: usui t. J Urol. 1990 Sep;144(3):662-5. doi: 10.1016/s0022-5347(17)39548-4. J Urol. 1990. PMID: 2388322

8

[M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].

Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Nakatsu H, Kume T, Kodama M, Masu C, et al. Igawa M, et al. Among authors: usui t. Hinyokika Kiyo. 1989 Aug;35(8):1323-7. Hinyokika Kiyo. 1989. PMID: 2683648 Free article. Clinical Trial. Japanese.

9

M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.

Igawa M, Kadena H, Ueda M, Usui T. Igawa M, et al. Among authors: usui t. Cancer Chemother Pharmacol. 1994;35 Suppl:S1-4. doi: 10.1007/BF00686909. Cancer Chemother Pharmacol. 1994. PMID: 7527732 Clinical Trial.

10

M-VEC (methotrexate, vinblastine, 4'-epirubicin and cisplatin) combined with glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the treatment of transitional cell carcinoma of urothelium: reduction in toxicity produced by rhG-CSF.

Ueda M, Igawa M, Kadena H, Usui T. Ueda M, et al. Among authors: usui t. Int J Urol. 1994 Sep;1(3):223-7. doi: 10.1111/j.1442-2042.1994.tb00039.x. Int J Urol. 1994. PMID: 7542154 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,945 results

Search Page

Filters